Our People: Growth Over Time 1.300 1,189 1.200 1.100 1.000 900 800 700 600 500 400 300 200 100 0 2007 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Employee Engagement & Development With talented and ambitious teams, our company culture continues to be dynamic and fast-paced
Anaphylaxis was reported in a post-marketing clinical trial in one patient who had previous exposure to XIAFLEX for the treatment of Dupuytrens contracture
6, 10 and 14 week old) were perfused transcardially with 10 ml PBS followed by 50 ml fixative containing 3% PFA and 1% acrolein (Merck, Germany) in 0.1 M PB
Calcium signaling in lysosome-dependent cell death
* Correspondence: Guojing Zhao, [email protected]
NEITHER MTA NOR ITS AFFILIATES NOR ANY THIRD PARTY SUPPLIER CAN BE ASSURED THAT THE USER, IN USING THIS SITE, HAS SELECTED AN APPROPRIATE SERVICE PROVIDER